- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- September 2024
- 88 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Dermatomycoses drugs are a type of dermatological drug used to treat fungal infections of the skin, hair, and nails. These drugs are typically administered topically, either as creams, ointments, or powders, and are often used in combination with other antifungal agents. Common active ingredients in dermatomycoses drugs include clotrimazole, miconazole, terbinafine, and ketoconazole. These drugs are used to treat a variety of fungal infections, including athlete's foot, jock itch, ringworm, and yeast infections.
The dermatomycoses drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. These companies include Bayer, Novartis, Pfizer, Merck, and GlaxoSmithKline. Additionally, there are a number of smaller companies that specialize in the production of dermatomycoses drugs, such as Galderma, Mylan, and Perrigo. Show Less Read more